The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
Open accessAbstract
Cell-penetrating peptides (CPPs) are short peptides (fewer than 30 amino acids) that have been predominantly used in basic and preclinical research during the last 30 years. Since they are not only capable of translocating themselves into cells but also facilitate drug or CPP/cargo complexes to translocate across the plasma membrane, they have potential applications in the disease diagnosis and therapy, including cancer, inflammation, central nervous system disorders, otologic and ocular disorders, and diabetes. However, no CPPs or CPP/cargo complexes have been approved by the US Food and Drug Administration (FDA). Many issues should be addressed before translating CPPs into clinics. In this review, we summarize recent developments and innovations in preclinical studies and clinical trials based on using CPP for improved delivery, which have revealed that CPPs or CPP-based delivery systems present outstanding diagnostic therapeutic delivery potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
Vivès, E., Brodin, P., & Lebleu, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.16010 · Cited by 2,373
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Single-cell RNA sequencing technologies and bioinformatics pipelines
Hwang, B., Lee, J. H., & Bang, D. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0071-8 · Cited by 1,781
Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662
Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Green, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553
Cell-Penetrating Peptides: From Basic Research to Clinics
Guidotti, G., Brambilla, L., & Rossi, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.01.003 · Cited by 1,147
Polyarginine enters cells more efficiently than other polycationic homopolymers
Mitchell, D. J., Steinman, L., Kim, D. T., Fathman, C. G., & Rothbard, J. B. (2000) · The Journal of Peptide Research · doi:10.1034/j.1399-3011.2000.00723.x · Cited by 1,084
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408191101 · Cited by 822
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813
Lindgren, M., Hällbrink, M., Prochiantz, A., & Langel, Ü. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01447-4 · Cited by 803
Cell-penetrating peptides: mechanism and kinetics of cargo delivery
Zorko, M., & Langel, Ü. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.010 · Cited by 799
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
Yang, Z., Shi, J., Xie, J., Wang, Y., Sun, J., Liu, T., Zhao, Y., Zhao, X., Wang, X., Ma, Y., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0485-1 · Cited by 744
Self-citationAntennapedia homeobox peptide regulates neural morphogenesis.
Joliot, A., Pernelle, C., Deagostini-Bazin, H., & Prochiantz, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1864 · Cited by 654
GUPTA, B., LEVCHENKO, T., & TORCHILIN, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.007 · Cited by 632
Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., & Chernomordik, L. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m401604200 · Cited by 604
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Olson, E. S., Jiang, T., Aguilera, T. A., Nguyen, Q. T., Ellies, L. G., Scadeng, M., & Tsien, R. Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910283107 · Cited by 567
Tickets to ride: selecting cargo for clathrin-regulated internalization
Traub, L. M. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2751 · Cited by 565
Nanoplatforms for Targeted Molecular Imaging in Living Subjects
Cai, W., & Chen, X. (2007) · Small · doi:10.1002/smll.200700351 · Cited by 563
Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 489
Simeoni, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg385 · Cited by 480
Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins
Fittipaldi, A., Ferrari, A., Zoppé, M., Arcangeli, C., Pellegrini, V., Beltram, F., & Giacca, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303045200 · Cited by 475
Mitochondria-Penetrating Peptides
Horton, K. L., Stewart, K. M., Fonseca, S. B., Guo, Q., & Kelley, S. O. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.03.015 · Cited by 465
El-Sayed, A., Futaki, S., & Harashima, H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9071-2 · Cited by 465
Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T.-Y., & Pellois, J.-P. (2012) · Pharmaceuticals · doi:10.3390/ph5111177 · Cited by 384
Cell penetrating peptides: A concise review with emphasis on biomedical applications
Derakhshankhah, H., & Jafari, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.097 · Cited by 379
Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery
Wang, F., Wang, Y., Zhang, X., Zhang, W., Guo, S., & Jin, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.020 · Cited by 377
A New Potent Secondary Amphipathic Cell–penetrating Peptide for siRNA Delivery Into Mammalian Cells
Crombez, L., Aldrian-Herrada, G., Konate, K., Nguyen, Q. N., McMaster, G. K., Brasseur, R., Heitz, F., & Divita, G. (2009) · Molecular Therapy · doi:10.1038/mt.2008.215 · Cited by 346
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
Cho, C.-F., Wolfe, J. M., Fadzen, C. M., Calligaris, D., Hornburg, K., Chiocca, E. A., Agar, N. Y. R., Pentelute, B. L., & Lawler, S. E. (2017) · Nature Communications · doi:10.1038/ncomms15623 · Cited by 336
Mechanism Matters: A Taxonomy of Cell Penetrating Peptides
Kauffman, W. B., Fuselier, T., He, J., & Wimley, W. C. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.10.004 · Cited by 333
Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents
Szeto, H. H. (2006) · The AAPS Journal · doi:10.1208/aapsj080362 · Cited by 332
CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides
Agrawal, P., Bhalla, S., Usmani, S. S., Singh, S., Chaudhary, K., Raghava, G. P. S., & Gautam, A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1266 · Cited by 332
Secondary structure of cell-penetrating peptides controls membrane interaction and insertion
Eiríksdóttir, E., Konate, K., Langel, Ü., Divita, G., & Deshayes, S. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.03.005 · Cited by 323
Kristensen, M., Birch, D., & Mørck Nielsen, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020185 · Cited by 304
Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides
Qian, Z., Martyna, A., Hard, R. L., Wang, J., Appiah-Kubi, G., Coss, C., Phelps, M. A., Rossman, J. S., & Pei, D. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00226 · Cited by 296
Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents
Borrelli, A., Tornesello, A., Tornesello, M., & Buonaguro, F. (2018) · Molecules · doi:10.3390/molecules23020295 · Cited by 295
Nanopreparations for organelle-specific delivery in cancer
Biswas, S., & Torchilin, V. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.004 · Cited by 292
Lo, S. L., & Wang, S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.031 · Cited by 290
Cell-penetrating peptides: A comparative membrane toxicity study
Saar, K., Lindgren, M., Hansen, M., Eiríksdóttir, E., Jiang, Y., Rosenthal-Aizman, K., Sassian, M., & Langel, Ü. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.07.033 · Cited by 290
Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems
Trabulo, S., Cardoso, A. L., Mano, M., & De Lima, M. C. P. (2010) · Pharmaceuticals · doi:10.3390/ph3040961 · Cited by 290
Live‐cell analysis of cell penetration ability and toxicity of oligo‐arginines
Tünnemann, G., Ter‐Avetisyan, G., Martin, R. M., Stöckl, M., Herrmann, A., & Cardoso, M. C. (2008) · Journal of Peptide Science · doi:10.1002/psc.968 · Cited by 286
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
Chen, H., Niu, G., Wu, H., & Chen, X. (2016) · Theranostics · doi:10.7150/thno.13242 · Cited by 282
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Habault, J., & Poyet, J.-L. (2019) · Molecules · doi:10.3390/molecules24050927 · Cited by 280
Reissmann, S. (2014) · Journal of Peptide Science · doi:10.1002/psc.2672 · Cited by 266
A Review on Electroporation-Based Intracellular Delivery
Shi, J., Ma, Y., Zhu, J., Chen, Y., Sun, Y., Yao, Y., Yang, Z., & Xie, J. (2018) · Molecules · doi:10.3390/molecules23113044 · Cited by 261
Self-citationFretz, M. M., Penning, N. A., Al-Taei, S., Futaki, S., Takeuchi, T., Nakase, I., Storm, G., & Jones, A. T. (2007) · Biochemical Journal · doi:10.1042/bj20061808 · Cited by 257
Arginine-rich peptides and their internalization mechanisms
Futaki, S., Nakase, I., Tadokoro, A., Takeuchi, T., & Jones, A. T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350784 · Cited by 246
Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapy
Rassu, G., Soddu, E., Posadino, A. M., Pintus, G., Sarmento, B., Giunchedi, P., & Gavini, E. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.01.031 · Cited by 239
Radiolabeled Nanoparticles for Multimodality Tumor Imaging
Xing, Y., Zhao, J., Conti, P. S., & Chen, K. (2014) · Theranostics · doi:10.7150/thno.7341 · Cited by 234
Peptide-based imaging agents for cancer detection
Sun, X., Li, Y., Liu, T., Li, Z., Zhang, X., & Chen, X. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.007 · Cited by 224
Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation
Yang, Z., Xie, J., Zhu, J., Kang, C., Chiang, C., Wang, X., Wang, X., Kuang, T., Chen, F., Chen, Z., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.008 · Cited by 217
Self-citationHuang, Y., Jiang, Y., Wang, H., Wang, J., Shin, M. C., Byun, Y., He, H., Liang, Y., & Yang, V. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.007 · Cited by 209
Proline-rich, amphipathic cell-penetrating peptides
Pujals, S., & Giralt, E. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.012 · Cited by 209
Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-800092-2.00001-0 · Cited by 204
A splice variant of human Bmal1 acts as a negative regulator of the molecular circadian clock
Lee, J., Park, E., Kim, G. H., Kwon, I., & Kim, K. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0187-x · Cited by 200
Aguilera, T. A., Olson, E. S., Timmers, M. M., Jiang, T., & Tsien, R. Y. (2009) · Integrative Biology · doi:10.1039/b904878b · Cited by 198
Functional peptides for siRNA delivery
Tai, W., & Gao, X. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.08.004 · Cited by 197
Cell‐Penetrating Homochiral Cyclic Peptides as Nuclear‐Targeting Molecular Transporters
Mandal, D., Nasrolahi Shirazi, A., & Parang, K. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201102572 · Cited by 191
Nakase, I., Noguchi, K., Aoki, A., Takatani-Nakase, T., Fujii, I., & Futaki, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-02014-6 · Cited by 182
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
Quach, N. D., Arnold, R. D., & Cummings, B. S. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.05.022 · Cited by 180
Cell‐penetrating peptides: Nanocarrier for macromolecule delivery in living cells
Chugh, A., Eudes, F., & Shim, Y. (2010) · IUBMB Life · doi:10.1002/iub.297 · Cited by 170
Zhu, Z., Tian, D., Gao, P., Wang, K., Li, Y., Shu, X., Zhu, J., & Zhao, Q. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08438 · Cited by 170
Nanoparticles for Cancer Targeting: Current and Future Directions
Swain, S., Sahu, P., Beg, S., & Babu, S. (2016) · Current Drug Delivery · doi:10.2174/1567201813666160713121122 · Cited by 169
Nanotechnology for the delivery of phytochemicals in cancer therapy
Xie, J., Yang, Z., Zhou, C., Zhu, J., Lee, R. J., & Teng, L. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.04.002 · Cited by 168
Self-citationA novel approach using functional peptides for efficient intestinal absorption of insulin
Morishita, M., Kamei, N., Ehara, J., Isowa, K., & Takayama, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.022 · Cited by 165
Mechanism of Uptake of C105Y, a Novel Cell-penetrating Peptide
Rhee, M., & Davis, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509813200 · Cited by 164
Dinca, A., Chien, W.-M., & Chin, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020263 · Cited by 164
Thennarasu, S., Tan, A., Penumatchu, R., Shelburne, C. E., Heyl, D. L., & Ramamoorthy, A. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.09.060 · Cited by 163
Peptide-based nanoprobes for molecular imaging and disease diagnostics
Zhang, P., Cui, Y., Anderson, C. F., Zhang, C., Li, Y., Wang, R., & Cui, H. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00793k · Cited by 160
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
McClorey, G., & Banerjee, S. (2018) · Biomedicines · doi:10.3390/biomedicines6020051 · Cited by 160
Savariar, E. N., Felsen, C. N., Nashi, N., Jiang, T., Ellies, L. G., Steinbach, P., Tsien, R. Y., & Nguyen, Q. T. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2969 · Cited by 159
Lulla, R. R., Goldman, S., Yamada, T., Beattie, C. W., Bressler, L. R., Pacini, M., Pollack, I. F., Fisher, P. G., Packer, R. J., Dunkel, I. J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now047 · Cited by 152
Nielsen, E. J. B., Yoshida, S., Kamei, N., Iwamae, R., Khafagy, E., Olsen, J., Rahbek, U. L., Pedersen, B. L., Takayama, K., & Takeda‐Morishita, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.022 · Cited by 151
Xu, J., Khan, A. R., Fu, M., Wang, R., Ji, J., & Zhai, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.020 · Cited by 151
Yang, S., Zaitseva, E., Chernomordik, L., & Melikov, K. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.08.029 · Cited by 147
In vivo biodistribution and efficacy of peptide mediated delivery
Järver, P., Mäger, I., & Langel, Ü. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.07.006 · Cited by 145
Cell‐penetrating peptides: Achievements and challenges in application for cancer treatment
Shin, M. C., Zhang, J., Min, K. A., Lee, K., Byun, Y., David, A. E., He, H., & Yang, V. C.-M. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34859 · Cited by 144
Induction of splice correction by cell‐penetrating peptide nucleic acids
Andaloussi, S. E., Johansson, H. J., Lundberg, P., & Langel, Ü. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.950 · Cited by 141
de Coupade, C., Fittipaldi, A., Chagnas, V., Michel, M., Carlier, S., Tasciotti, E., Darmon, A., Ravel, D., Kearsey, J., Giacca, M., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050401 · Cited by 139
Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy
Tripathi, P. P., Arami, H., Banga, I. K., Gupta, J. R. P., & Gandhi, S. (2018) · Oncotarget · doi:10.18632/oncotarget.26442 · Cited by 135
Nanotechnology platforms for cancer immunotherapy
Yang, Z., Ma, Y., Hai, Z., Yuan, Y., & Kim, B. Y. S. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1590 · Cited by 134
Self-citationHyeon, L. S., Moroz, E., Castagner, B., & Leroux, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja507547w · Cited by 129
Novel cell‐penetrating peptide targeting mitochondria
Cerrato, C. P., Pirisinu, M., Vlachos, E. N., & Langel, Ü. (2015) · The FASEB Journal · doi:10.1096/fj.14-269225 · Cited by 127
Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency
Liang, J. F., & Yang, V. C.-M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.142 · Cited by 124
Yin, T., Xie, W., Sun, J., Yang, L., & Liu, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b05089 · Cited by 123
Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
Walrant, A., Cardon, S., Burlina, F., & Sagan, S. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00455 · Cited by 121
Characterization of a Novel Cytotoxic Cell‐penetrating Peptide Derived From p14ARF Protein
Johansson, H. J., Andaloussi, S. E., Holm, T., Mäe, M. A., Jänes, J., Maimets, T., & Langel, Ü. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300346 · Cited by 119
He, H., Ye, J., Liu, E., Liang, Q., Liu, Q., & Yang, V. C.-M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.056 · Cited by 119
Cell penetrating peptides in ocular drug delivery: State of the art
Pescina, S., Ostacolo, C., Gomez-Monterrey, I. M., Sala, M., Bertamino, A., Sonvico, F., Padula, C., Santi, P., Bianchera, A., & Nicoli, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.023 · Cited by 118
Zhao, H., Wu, M., Zhu, L., Tian, Y., Wu, M., Li, Y., Deng, L., Jiang, W., Shen, W., Wang, Z., et al. (2018) · Theranostics · doi:10.7150/thno.22386 · Cited by 107
The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain
Sharma, G., Lakkadwala, S., Modgil, A., & Singh, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060806 · Cited by 103
Delivery of Nanoparticles for Treatment of Brain Tumor
Chen, K., Sun, Y., Zhu, J., Li, W., Zhang, A., Kuang, T., Xie, J., & Yang, Z. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160728152939 · Cited by 103
Self-citationMiampamba, M., Liu, J., Harootunian, A. T., Gale, A. J., Baird, S. M., Chen, S. L., Nguyen, Q. T., Tsien, R. Y., & González, J. E. (2017) · Theranostics · doi:10.7150/thno.20678 · Cited by 101
Doss, M., Kolb, H. C., Zhang, J., Bélanger, M.-J., Stubbs, J. B., Stabin, M. G., Hostetler, E. D., Alpaugh, R. K., von Mehren, M., Walsh, J. C., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.088955 · Cited by 100
Staecker, H., Joković, G., Карпищенко, С. А., Kienle-Gogolok, A., Krzyzaniak, A., Lin, C., Navratil, P., Tzvetkov, V., Wright, N., & Meyer, T. S. (2019) · Otology & Neurotology · doi:10.1097/mao.0000000000002229 · Cited by 97
Yang, Z., Yu, B., Zhu, J., Huang, X., Xie, J., Xu, S., Yang, X., Wang, X., Yung, B. C., Lee, L. J., et al. (2014) · Nanoscale · doi:10.1039/c4nr01510j · Cited by 95
Self-citationCell-penetrating Peptides: Efficient Vectors for Vaccine Delivery
Yang, J., Luo, Y., Shibu, M. A., Tóth, I., & Skwarczyński, M. (2019) · Current Drug Delivery · doi:10.2174/1567201816666190123120915 · Cited by 95
Poly-Arginine and Arginine-Rich Peptides are Neuroprotective in Stroke Models
Meloni, B. P., Brookes, L. M., Clark, V. W., Cross, J. L., Edwards, A. B., Anderton, R. S., Hopkins, R. M., Hoffmann, K., & Knuckey, N. W. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.11 · Cited by 92
Melittin derived peptides for nanoparticle based siRNA transfection
Hou, K. K., Pan, H., Lanza, G. M., & Wickline, S. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.037 · Cited by 91
Gao, L., Yu, J. H., Liu, Y., Zhou, J., Sun, L., Wang, J., Zhu, J., Peng, H., Lu, W., Yu, L., et al. (2017) · Theranostics · doi:10.7150/thno.21074 · Cited by 90
Penetratin, a Potentially Powerful Absorption Enhancer for Noninvasive Intraocular Drug Delivery
Liu, C., Tai, L., Zhang, W., Wei, G., Pan, W., & Lu, W. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400681n · Cited by 89
Biological responses towards cationic peptides and drug carriers
Verdurmen, W. P. R., & Brock, R. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.005 · Cited by 88
Unkart, J., Chen, S. L., Wapnir, I., González, J. E., Harootunian, A. T., & Wallace, A. M. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5991-3 · Cited by 88
Tang, B., Zaro, J. L., Shen, Y., Qian, C., Yu, Y., Sun, P., Wang, Y., Shen, W., Tu, J., & Sun, C. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.016 · Cited by 83
Onoshima, D., Yukawa, H., & Baba, Y. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.08.004 · Cited by 80
iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer
Lo, J. H.-J., Hao, L., Muzumdar, M. D., Raghavan, S., Kwon, E. J., Pulver, E. M., Hsu, F., Aguirre, A. J., Wolpin, B. M., Fuchs, C. S., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1090 · Cited by 80
Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity
Gómez, J. A., Chen, J., Ngo, J., Hájková, D., Yeh, I., Gama, V., Miyagi, M., & Matsuyama, S. (2010) · Pharmaceuticals · doi:10.3390/ph3123594 · Cited by 78
Intelligent substance delivery into cells using cell-penetrating peptides
Tashima, T. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.11.083 · Cited by 77
Yang, X., Yang, S., Chai, H., Yang, Z., Lee, R. J., Liao, W., & Teng, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136649 · Cited by 74
Self-citationPae, J., Säälik, P., Liivamägi, L., Lubenets, D., Arukuusk, P., Langel, Ü., & Pooga, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.002 · Cited by 73
Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes
Hansen, M. B., van Gaal, E. V. B., Minten, I. J., Storm, G., van Hest, J. C. M., & Löwik, D. W. P. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.008 · Cited by 72
Cell-penetrating peptides for siRNA delivery to glioblastomas
Srimanee, A., Arvanitidou, M., Kim, K., Hällbrink, M., & Langel, Ü. (2018) · Peptides · doi:10.1016/j.peptides.2018.04.015 · Cited by 72
Kang, Y. C., Son, M., Kang, S., Im, S., Piao, Y., Lim, K. S., Song, M., Park, K.-S., Kim, Y. H., & Pak, Y. K. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0124-z · Cited by 72
gH625: A milestone in understanding the many roles of membranotropic peptides
Galdiero, S., Falanga, A., Morelli, G., & Galdiero, M. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.006 · Cited by 71
Kim, J. Y., Ahn, J., Kim, J., Choi, M., Jeon, H., Choe, K., Lee, D. Y., Kim, P., & Jon, S. (2018) · ACS Nano · doi:10.1021/acsnano.8b02330 · Cited by 71
Polyethylenimine-based Formulations for Delivery of Oligonucleotides
Hao, F., Li, Y., Zhu, J., Sun, J., Marshall, B., Lee, R. J., Teng, L., Yang, Z., & Xie, J. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181031094759 · Cited by 71
Self-citationTian, Y., Zhou, M., Shi, H., Gao, S., Xie, G., Zhu, M., Wu, M., Chen, J., & Niu, Z. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01805 · Cited by 70
Jiao, X., Yu, Y., Meng, J., He, M., Zhang, C. J., Geng, W., Ding, B., Wang, Z., & Ding, X. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.12.001 · Cited by 70
Ahlschwede, K. M., Curran, G. L., Rosenberg, J. T., Grant, S. C., Sarkar, G., Jenkins, R. B., Ramakrishnan, S., Poduslo, J. F., & Kandimalla, K. K. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.09.010 · Cited by 69
Guo, F., Ouyang, T., Peng, T., Zhang, X., Xie, B., Yang, X., Liang, D., & Zhong, H. (2019) · Biomaterials Science · doi:10.1039/c8bm01485j · Cited by 67
Clinical Applications of Radiolabeled Peptides for PET
Jackson, I. M., Scott, P. J. H., & Thompson, S. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.05.007 · Cited by 64
Kadonosono, T., Yamano, A., Goto, T., tsubaki, T., Niibori, M., Kuchimaru, T., & Kizaka‐Kondoh, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.011 · Cited by 62
Chu, Y., Chen, N., Yu, H., Mu, H., He, B., Hua, H., Wang, A., & Sun, K. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s126865 · Cited by 61
Islam, M. Z., Sharmin, S., Moniruzzaman, M., & Yamazaki, M. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-8889-5 · Cited by 61
A Polyethylenimine-Linoleic Acid Conjugate for Antisense Oligonucleotide Delivery
Xie, J., Teng, L., Yang, Z., Zhou, C., Liu, Y., Yung, B. C., & Lee, R. J. (2013) · BioMed Research International · doi:10.1155/2013/710502 · Cited by 58
Self-citationLev, N., Barhum, Y., Ben‐Zur, T., Aharony, I., Trifonov, L., Regev, N., Melamed, E., Gruzman, A., & Offen, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127549 · Cited by 57
Baoum, A. A., Ovcharenko, D., & Berkland, C. J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.012 · Cited by 57
Ye, J., Shin, M. C., Liang, Q., He, H., & Yang, V. C.-M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.002 · Cited by 56
Kim, M. J., Park, M., Kim, D. W., Shin, M. J., Son, O., Jo, H. S., Yeo, H. J., Cho, S. B., Park, J. H., Lee, C. H., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.015 · Cited by 53
Chiquet, C., Aptel, F., Creuzot-Garcher, C., Berrod, J.-P., Kodjikian, L., Massin, P., Deloche, C., Perino, J., Kirwan, B.-A., de Brouwer, S., et al. (2017) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.10.012 · Cited by 52
Tian, Y., Mi, G., Chen, Q., Chaurasiya, B., Li, Y., Shi, D., Zhang, Y., Webster, T. J., Sun, C., & Shen, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b15147 · Cited by 51
Kristensen, M., Franzyk, H., Klausen, M. T., Iversen, A. K. S., Bahnsen, J. S., Skyggebjerg, R. B., Foderà, V., & Nielsen, H. M. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9747-3 · Cited by 47
Hu, H., Wang, J., Wang, H., Tan, T., Li, J., Wang, Z., Sun, K., Li, Y., & Zhang, Z. (2018) · Theranostics · doi:10.7150/thno.25608 · Cited by 46
Nanomedicine based on Nucleic Acids: Pharmacokinetic and Pharmacodynamic Perspectives
Zhou, C., Yang, Z., & Teng, L. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666141020155620 · Cited by 45
Self-citationLiu, Y., Song, Z., Zheng, N., Nagasaka, K., Yin, L., & Cheng, J. (2018) · Nanoscale · doi:10.1039/c8nr03976c · Cited by 45
Bioactive cell penetrating peptides and proteins in cancer: a bright future ahead
Jauset, T., & Beaulieu, M.-È. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.03.014 · Cited by 45
Chen, S., Cui, J., Jiang, T., Olson, E. S., Cai, Q.-Y., Yang, M., Wu, W., Guthrie, J. M., Robertson, J. D., Lipton, S. A., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621573 · Cited by 44
TP10-Dopamine Conjugate as a Potential Therapeutic Agent in the Treatment of Parkinson’s Disease
Rusiecka, I., Ruczyński, J., Kozłowska, A., Backtrog, E., Mucha, P., Kocić, I., & Rekowski, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00894 · Cited by 44
Moutal, A., François‐Moutal, L., Brittain, J. M., Khanna, M., & Khanna, R. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00471 · Cited by 43
Capron, M., Béghin, L., Leclercq, C., Labreuche, J., Dendooven, A., Standaert‐Vitse, A., Delbeke, M., Porcherie, A., Nachury, M., Boruchowicz, A., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010041 · Cited by 41
Jeong, E. J., Choi, M., Lee, J., Rhim, T., & Lee, K. Y. (2015) · Nanoscale · doi:10.1039/c5nr06903c · Cited by 40
Meng, F., Sun, Y., Lee, R. J., Wang, G., Zheng, X., Zhang, H., Fu, Y., Yan, G.-J., Wang, Y., Deng, W., et al. (2019) · Cancers · doi:10.3390/cancers11101571 · Cited by 40
Self-citationPreclinical and clinical otoprotective applications of cell-penetrating peptide D-JNKI-1 (AM-111)
Eshraghi, A. A., Aranke, M., Salvi, R., Ding, D., Coleman, J. K. M., Ocak, E., Mittal, R., & Meyer, T. S. (2018) · Hearing Research · doi:10.1016/j.heares.2018.03.003 · Cited by 39
Chu, D., Xu, W., Ran, P., Ding, Y., Sui, W., & Chen, P. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.08.007 · Cited by 38
Cationic Cell-Penetrating Peptides as Vehicles for siRNA Delivery
Beloor, J., Zeller, S., Choi, C. S., Lee, S., & Kumar, P. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.2 · Cited by 38
Homologous recombination in Leishmania enriettii.
Tobin, J. F., Laban, A., & Wirth, D. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.864 · Cited by 36
ATTEMPTS System: A Macromolecular Prodrug Strategy for Cancer Drug Delivery
Huang, Y., Park, Y. S., Wang, J., Moon, C., Kwon, Y. M., Chung, H. S., Park, Y. J., & Yang, V. C.-M. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920441 · Cited by 36
Zhang, Z., Yuan, Y., Liu, Z., Chen, H., Chen, D., Fang, X., Zheng, J., Qin, W., & Wu, C. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b08735 · Cited by 36
Gao, P., Mei, C., He, L., Xiao, Z., Chan, L., Zhang, D., Shi, C., Chen, T., & Luo, L. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1494224 · Cited by 36
Zhao, X.-L., Chen, B., Han, J.-C., Wei, L., & Pan, X.-B. (2015) · Scientific Reports · doi:10.1038/srep17640 · Cited by 34
Selective Uptake Into Drug Resistant Mammalian Cancer by Cell Penetrating Peptide-Mediated Delivery
Carnevale, K. J. F., Muroski, M. E., Vakil, P. N., Foley, M. E., Laufersky, G., Kenworthy, R., Zorio, D. A. R., Morgan, T. J., Levenson, C. W., & Strouse, G. F. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00429 · Cited by 30
Shin, M. C., Zhao, J., Zhang, J., Huang, Y., He, H., Wang, M., Min, K. A., & Yang, V. C.-M. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35188 · Cited by 29
Coriat, R., Faivre, S. J., Mir, O., Dreyer, C., Ropert, S., Bouattour, M., Desjardins, R., Goldwasser, F., & Raymond, É. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s110274 · Cited by 28
Membrane Mechanics in Living Cells
Groves, J. T. (2019) · Developmental Cell · doi:10.1016/j.devcel.2018.12.011 · Cited by 27
Cell-penetrating peptide-based non-invasive topical delivery systems
Nguyen, T. V., Shin, M. C., Min, K. A., Huang, Y., Oh, E., & Moon, C. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0373-1 · Cited by 26
Tai, L., Liu, C., Jiang, K., Chen, X., Wei, G., Lu, W., & Pan, W. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.04.011 · Cited by 25
Gao, W., Yang, X., Lin, Z., He, B., Mei, D., Wang, D., Zhang, H., Zhang, H., Dai, W., Wang, X., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.018 · Cited by 23
Self-citationLee, Y. Y., Lee, S. Y., Park, S., Choi, H., Kim, E., & Han, J. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0083-4 · Cited by 20
Enhanced cellular uptake of lactosomes using cell-penetrating peptides
Akahoshi, A., Matsuura, E., Ozeki, E., Matsui, H., Watanabe, K., & Ohtsuki, T. (2016) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2016.1178056 · Cited by 18
Chen, Y., Fu, Y., Li, X., Chen, H., Wang, Z., & Zhang, H. (2019) · RSC Advances · doi:10.1039/c9ra02135c · Cited by 18
Self-citationGrasso, G., Mercuri, S., Danani, A., & Deriu, M. A. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b08106 · Cited by 18
Mechanism of Four de Novo Designed Antimicrobial Peptides
Murray, B., Pearson, C., Aranjo, A., Cherupalla, D., & Belfort, G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.733816 · Cited by 16
Novel Cell Model for Tauopathy Induced by a Cell-Permeable Tau-Related Peptide
Veloria, J. R., Li, L., Breen, G. A. M., & Goux, W. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00275 · Cited by 16
A new MAP-Rasagiline conjugate reduces α-synuclein inclusion formation in a cell model
Vale, N., Alves, C., Sharma, V., Lázaro, D. F., Silva, S., Gomes, P. A. C., & Outeiro, T. F. (2020) · Pharmacological Reports · doi:10.1007/s43440-019-00032-x · Cited by 15
Khandia, R., Munjal, A. K., Kumar, A., Singh, G., Karthik, K., & Dhama, K. (2017) · International Journal of Pharmacology · doi:10.3923/ijp.2017.677.689 · Cited by 13
Cited by
On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
Formica, M. L., Real, D. A., Picchio, M. L., Catlin, E., Donnelly, R. F., & Paredes, A. J. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101631 · Cited by 282
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Qian, L., Lin, X., Gao, X., Khan, R. U., Liao, J.-Y., Du, S., Ge, J., Zeng, S., & Yao, S. Q. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00915 · Cited by 155
Zhao, X., Seah, I., Xue, K., Wong, W., Tan, Q. S. W., Ma, X., Lin, Q., Lim, J. Y. C., Liu, Z., Parikh, B. H., et al. (2022) · Advanced Materials · doi:10.1002/adma.202108360 · Cited by 84
Cell penetrating peptide: A potent delivery system in vaccine development
Hasannejad-Asl, B., Pooresmaeil, F., Takamoli, S., Dabiri, M., & Bolhassani, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1072685 · Cited by 40
Advances and prospects of cell-penetrating peptides in tumor immunotherapy
Yang, D., Liu, B., & Sha, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-86130-8 · Cited by 31
Metadata
- Authors
- Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-05-20
- Volume
- 11
- Pages
- 697-697
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3026323285
- Cited by
- 466
- References
- 169
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.